Knee Osteoarthritis, Motor Control, Risk of Falls and Virtual Reality
Launched by UNIVERSIDADE DA CORUÑA · Apr 8, 2024
Trial Information
Current as of November 07, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying knee osteoarthritis, which is a common condition that affects the knees, particularly in adults aged 60 and older. The researchers want to find out how this condition impacts daily activities and the risk of falling. They are specifically looking at whether using virtual reality (VR) exercises can help reduce knee pain, improve movement, and lower the chances of falls compared to traditional physiotherapy, which typically involves physical exercises.
To participate, you need to be over 60 years old, able to walk on your own (even with assistance), and have a diagnosis of knee osteoarthritis. During the trial, you would fill out questionnaires, perform physical tests using motion capture technology, and complete exercises in a virtual reality setting. It’s important to note that this trial is not yet recruiting participants, and some health conditions, like severe dizziness or recent major injuries, would exclude you from participating. This study could be a great opportunity to explore a new way to manage knee osteoarthritis and improve overall well-being!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age over 60 years.
- • Non-institutionalized individuals.
- • Subjects who wish and consent through informed consent to participate in the study.
- • Have the ability to walk independently (with or without assistive devices).
- • Diagnosis of primary knee osteoarthritis according to the clinical and radiological criteria of the American College of Rheumatology.
- • Specifically, for phase 1, subjects without a knee osteoarthritis diagnosis will also be included.
- Exclusion Criteria:
- • History of significant previous traumas or surgeries to the spine, pelvis, or legs in the last 12 months.
- • Self-reported presence of dizziness, seizures, or epilepsy, aiming to prevent potential exacerbation of symptoms with VR.
- • Vestibular disorders (balance).
- • Neurological diseases, cardiovascular, or respiratory disorders affecting activity; as well as inflammatory or autoimmune diseases affecting the lower limb joints, and other forms of secondary osteoarthritis.
- • Diagnosis of a terminal illness or a health condition that prevents attendance.
- • To have a medical contraindication for exercise.
- • Body Mass Index (BMI) ≥ 40
About Universidade Da Coruña
Universidade da Coruña is a prominent academic institution located in Spain, dedicated to advancing research and education across various disciplines, including health sciences. As a clinical trial sponsor, the university leverages its robust faculty expertise and state-of-the-art facilities to conduct innovative research aimed at improving patient outcomes and enhancing medical knowledge. With a strong commitment to ethical standards and regulatory compliance, Universidade da Coruña fosters collaboration between researchers, clinicians, and industry partners to facilitate the development of novel therapies and interventions, ultimately contributing to the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Beatriz Rodríguez-Romero, PhD
Study Director
Universidade da Coruña
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported